Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 5
2007 3
2008 2
2010 2
2015 1
2017 3
2019 1
2020 4
2021 2
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

22 results
Results by year
Filters applied: . Clear all
Page 1
Anti-integrin therapy for retinovascular diseases.
Bhatwadekar AD, Kansara V, Luo Q, Ciulla T. Bhatwadekar AD, et al. Among authors: kansara v. Expert Opin Investig Drugs. 2020 Sep;29(9):935-945. doi: 10.1080/13543784.2020.1795639. Epub 2020 Sep 9. Expert Opin Investig Drugs. 2020. PMID: 32657172 Review.
Injectable lipid emulsions-advancements, opportunities and challenges.
Hippalgaonkar K, Majumdar S, Kansara V. Hippalgaonkar K, et al. Among authors: kansara v. AAPS PharmSciTech. 2010 Dec;11(4):1526-40. doi: 10.1208/s12249-010-9526-5. Epub 2010 Oct 26. AAPS PharmSciTech. 2010. PMID: 20976577 Free PMC article. Review.
Long-acting protein drugs for the treatment of ocular diseases.
Ghosh JG, Nguyen AA, Bigelow CE, Poor S, Qiu Y, Rangaswamy N, Ornberg R, Jackson B, Mak H, Ezell T, Kenanova V, de la Cruz E, Carrion A, Etemad-Gilbertson B, Caro RG, Zhu K, George V, Bai J, Sharma-Nahar R, Shen S, Wang Y, Subramanian KK, Fassbender E, Maker M, Hanks S, Vrouvlianis J, Leehy B, Long D, Prentiss M, Kansara V, Jaffee B, Dryja TP, Roguska M. Ghosh JG, et al. Among authors: kansara v. Nat Commun. 2017 Mar 23;8:14837. doi: 10.1038/ncomms14837. Nat Commun. 2017. PMID: 28332616 Free PMC article.
22 results